Thermo Fisher Scientific Inc. (TMO) Shares Sold by First Western Capital Management Co

First Western Capital Management Co reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 24,028 shares of the medical research company’s stock after selling 534 shares during the quarter. Thermo Fisher Scientific makes up 2.8% of First Western Capital Management Co’s investment portfolio, making the stock its 11th largest holding. First Western Capital Management Co’s holdings in Thermo Fisher Scientific were worth $4,546,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of TMO. Tudor Investment Corp ET AL lifted its holdings in shares of Thermo Fisher Scientific by 241.8% during the first quarter. Tudor Investment Corp ET AL now owns 8,545 shares of the medical research company’s stock worth $1,313,000 after buying an additional 6,045 shares during the last quarter. Flagship Harbor Advisors LLC lifted its holdings in shares of Thermo Fisher Scientific by 24.3% during the first quarter. Flagship Harbor Advisors LLC now owns 4,750 shares of the medical research company’s stock worth $725,000 after buying an additional 930 shares during the last quarter. B.S. Pension Fund Trustee Ltd acting for the British Steel Pension Fund lifted its holdings in shares of Thermo Fisher Scientific by 11.2% during the first quarter. B.S. Pension Fund Trustee Ltd acting for the British Steel Pension Fund now owns 16,527 shares of the medical research company’s stock worth $2,539,000 after buying an additional 1,658 shares during the last quarter. OLD Mutual Customised Solutions Proprietary Ltd. lifted its holdings in shares of Thermo Fisher Scientific by 15.5% during the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 13,172 shares of the medical research company’s stock worth $2,023,000 after buying an additional 1,772 shares during the last quarter. Finally, First Financial Equity Corporation acquired a new position in shares of Thermo Fisher Scientific during the first quarter worth approximately $224,000. Hedge funds and other institutional investors own 86.22% of the company’s stock.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $191.74, for a total value of $9,587,000.00. Following the sale, the chief executive officer now directly owns 302,577 shares in the company, valued at $58,016,113.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.49% of the company’s stock.

A number of brokerages have recently commented on TMO. Zacks Investment Research lowered Thermo Fisher Scientific from a “hold” rating to a “sell” rating in a report on Thursday. BTIG Research initiated coverage on Thermo Fisher Scientific in a research report on Friday, January 5th. They set a “buy” rating and a $230.00 price objective on the stock. Evercore ISI initiated coverage on Thermo Fisher Scientific in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 price objective on the stock. Leerink Swann restated an “outperform” rating and set a $200.00 price objective (down from $216.00) on shares of Thermo Fisher Scientific in a research report on Monday, December 4th. Finally, Deutsche Bank set a $226.00 price objective on Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Thursday, October 26th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and fifteen have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $212.21.

Shares of Thermo Fisher Scientific Inc. (NYSE TMO) traded up $1.51 during trading hours on Friday, reaching $210.17. The company’s stock had a trading volume of 1,486,500 shares, compared to its average volume of 1,680,000. Thermo Fisher Scientific Inc. has a 52-week low of $140.00 and a 52-week high of $211.54. The company has a market capitalization of $83,840.00, a PE ratio of 35.68, a price-to-earnings-growth ratio of 1.70 and a beta of 1.06. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The firm had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same period in the prior year, the business posted $2.03 earnings per share. The business’s revenue was up 13.9% compared to the same quarter last year. equities research analysts forecast that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.29%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.19%.

TRADEMARK VIOLATION WARNING: “Thermo Fisher Scientific Inc. (TMO) Shares Sold by First Western Capital Management Co” was published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://www.thelincolnianonline.com/2018/01/13/first-western-capital-management-co-sells-534-shares-of-thermo-fisher-scientific-inc-tmo-updated-updated.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply